(Left to right) Ben Shen led the study with Hindra, Jeffrey D. Rudolf, Ivana Crnov?i?, Dong Yang, Xiaohui Yan, Xiuling Li and Christoph Rader on the Florida campus of The Scripps Research Institute.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed an efficient process to rapidly discover new “enediyne natural products” from soil microbes that could be further developed into extremely potent anticancer drugs.
The study highlights microbial natural products as abundant sources of new drug leads. The researchers’ discovery process involves prioritizing the microbes from the TSRI strain collection and focusing on the ones that are genetically predisposed to produce specific families of natural products. The scientists say this process saves time and resources in comparison to the traditional approaches used to identify these rare molecules.
The study, led by TSRI Professor Ben Shen, was published today in the journal mBio.
Shen and his colleagues uncovered a new family of enediyne natural products, called tiancimycins, (TNMs) which kill selected cancer cells more rapidly and completely in comparison to toxic molecules used in FDA-approved antibody-drug conjugates (ADCs)— monoclonal antibodies attached to cytotoxic drugs that target only cancer cells.
The scientists also discovered several new producers of C-1027, an antitumor antibiotic currently in clinical development, which can produce C-1027 at much higher levels.
It has been more than a decade since Shen first reported on the C-1027 enediyne biosynthetic machinery, and he speculated then that the knowledge obtained from studying biosynthesis of C-1027, and other enediynes, could be used for the discovery of novel enediyne natural products.
“The enediynes represent one of the most fascinating families of natural products for their extraordinary biological activities,” Shen said. “By surveying 3,400 strains from the TSRI collection, we were able to identify 81 strains that harbor genes encoding enediynes. With what we know, we can predict novel structural insights that can be exploited to radically accelerate enediyne-based drug discovery and development.”
“The work described by the Shen group is an excellent example of what can be achieved by coupling state of the art genomic analyses of potential biosynthetic clusters and modern physicochemical techniques,” said David J. Newman, retired chief of the National Cancer Institute’s Natural Products Branch. “As a result of their work, the potential number of enediynes has significantly increased.”
Shen’s method of strain prioritization and genome mining means a far more efficient use of resources involved in the discovery process, targeting only those strains that look to produce the most important natural compounds.
“This study shows that the potential to rapidly discover new enediyne natural products from a large strain collection is within our reach,” said TSRI Research Associate Xiaohui Yan, one of four first authors of the study. “We also show the feasibility of manipulating tiancimycin biosynthesis in vivo, which means that sufficient quantities of these precious natural products can be reliably produced by microbial fermentation for drug development and eventual commercialization.”
Learn more: Scripps Florida Scientists Discover New Natural Source of Potent Anti-Cancer Drugs
Receive an email update when we add a new ANTI-CANCER DRUG article.
The Latest on: Anticancer drug
via Google News
The Latest on: Anticancer drug
- Study discusses impact of chemotherapy on immune cellson April 12, 2021 at 12:56 am
Despite chemotherapy working well initially, many patients experience relapse due to the development of resistance against these drugs. Professor Balkwill from the Queen Mary University of London said ...
- CD40 drug before surgery can benefit patients with early-stage pancreatic canceron April 11, 2021 at 9:44 pm
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, ...
- Study reveals new insights into the effects of chemotherapy on tumor microenvironmenton April 11, 2021 at 9:40 pm
Research from Queen Mary University of London has revealed novel insights into the effects of chemotherapy on the tumor microenvironment (TME).
- Immune-stimulating drug before surgery shows promise in early-stage pancreatic canceron April 11, 2021 at 9:48 am
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, ...
- The impact of chemotherapy on immune cells in the tumor microenvironmenton April 11, 2021 at 9:40 am
Research from Queen Mary University of London has revealed novel insights into the effects of chemotherapy on the tumour microenvironment (TME). The study, published today in Cancer Immunology ...
- Hydrogel releases cancer drugs in response to temperature and acidityon April 8, 2021 at 10:43 pm
Loading anti-cancer medicines into drug delivery vessels that can carry them to the site of the tumor before releasing them could offer new highly effective forms of treatment, and scientists in ...
- COVID-19 Pandemic Effect and Impact Analysis on Chemotherapy Induced Neutropenia Drug Market by 2027on April 8, 2021 at 11:13 am
Apr 08, 2021 (Market Insight Reports) -- The latest report as Chemotherapy Induced Neutropenia Drug Market acknowledges Size, Application Segment, Type, Regional Outlook, Market Demand, Latest Trends, ...
- Novel hydrogel carriers for anti-cancer drugs offer new hope for cancer treatmenton April 7, 2021 at 2:26 pm
Novel hydrogel carriers for anti-cancer drugs offer new hope for cancer treatment Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug ...
- Anti-cancer drug can treat Covid-19: S'pore-US studyon April 7, 2021 at 2:00 pm
A drug used in cancer treatment can treat patients with moderate to severe forms of Covid-19, according to a study by Singapore and United States researchers. They found that topotecan, which is used ...
via Bing News
One Comment
Robert
They should have a look at the research being done at Washington U in St Louis with a substance
found in bee venom, mellitin. It has been found to be effective against cancer, alzheimers and HIV.